Close
Close

Please select the human condition you are looking to test for to see our available solutions.

Prevent the Preventable.
Manage the Manageable.

1 in 4 pregnant women carry GBS in their body. Expectant mothers who are colonized with GBS can transmit the bacteria to their newborns during childbirth.

Prevent the Preventable.
Manage the Manageable.

1 in 4 pregnant women carry GBS in their body. Expectant mothers who are colonized with GBS can transmit the bacteria to their newborns during childbirth.

Learn more about GBS

Why test for GBS?

Those who test positive for GBS may not feel sick or have symptoms, but the bacteria can put newborns at risk when passed from the mother during childbirth. Approximately 50% will transmit GBS to their newborn, possibly causing sepsis, pneumonia or meningitis.

GBS disease can be life threatening. According to the CDC, 3 out of 50 babies will die from GBS infection.

There are ways to prevent early-onset Group B Strep (GBS) infections in newborns with our simple molecular test that provides results in about one hour – a mere hour for lifelong impact.

A Deeper Dive

MLO article that discusses the GBS Guidelines in the United States: “Lab Testing for GBS Screening Unchanged With New Guidelines”

The Journal of Maternal-Fetal & Neonatal Medicine article that discusses the GBS Guidelines in Europe: Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference

Why test with a simple molecular test?

Molecular performance eliminates all subjectivity related to traditional culture methods, which also results in fewer false negatives.

The sensitivity of culture is unreliable and is documented to be as low as 42%. The lack of sensitivity can be attributed to several factors including subjectivity, 4% of GBS isolates are nonhemolytic and therefore are undetectable on the culture plate. Overgrowth of normal flora can inhibit the ability to identify GBS colonies.

Testing for Group B Streptococcus (GBS) with molecular solution provides accurate results ensuring appropriate antibiotic therapy can be administered at delivery, if needed.

Education & Outreach tools for Group B Streptococcus (GBS)

As committed partners in the shared healthcare mission of improving patient outcomes and quality of life, a diagnostic platform itself does not drive essential testing demand and utilization. We are proud of the diagnostic portfolio we provide, and more proud that our support goes beyond the product you purchase.

Collaborating on educational outreach content with our collective subject matter expertise, we offer our partner educational and outreach tools – driving testing utilization as part of our total solution.

Click here to have one of our representatives reach out to discuss.

GBS – Facts to Know

GBS – Facts to Know — EU Version

"We want to catch them all." One Meridian Group B Strep user noted in their experience, 5% of GBS strains are non-β-hemolytic, and it was important to the staff to have this added level of sensitivity. Using Meridian’s GBS test optimized their ability to maintain this level of care and was of utmost importance to the lab. "It's given me so much peace."

Meridian Group B Strep customer

Testing Solutions

Get in touch with us

Contact Us

Welcome to

Please select your country to continue

Continue